Search results
Results From The WOW.Com Content Network
Pelvic actinomycosis is a rare but proven complication of use of intrauterine devices. In extreme cases, pelvic abscesses might develop. In extreme cases, pelvic abscesses might develop. Treatment of pelvic actinomycosis associated with intrauterine devices involves removal of the device and antibiotic treatment.
Actinomycosis is a rare infectious bacterial disease caused by the gram-positive Actinomyces species. [1] The name refers to ray-like appearance of the organisms in the granules. About 70% of infections are due to either Actinomyces israelii or A. gerencseriae . [ 1 ]
Frozen pelvis is often caused by endometriosis. [1]It can also be caused by cancer, such as late-stage ovarian cancers and rectal cancers. [1] [2] Abdominal actinomycosis can produce frozen pelvis in its later stages, especially after removal of an intrauterine contraceptive device. [3]
Doxycycline is added to most regimens in the treatment of pelvic infections to cover chlamydia and mycoplasma. Penicillin is effective for bacteremia caused by non-beta lactamase producing bacteria. However, other agents should be used for the therapy of bacteremia caused by beta-lactamase producing bacteria.
Actinomyces naeslundii is a Gram-positive, rod-shaped bacterium found in the mouth of humans. The species has been implicated in periodontal disease , as well as various tooth cavities . [ 1 ] In other cases, A. naeslundii is associated with good oral health.
And while bacterial meningitis can be life-threatening, "early treatment improves outcomes," says Nagata. "The best treatments start with a prompt diagnosis of what is causing the disease," echoes ...
Pelvic inflammatory disease, also known as pelvic inflammatory disorder (PID), is an infection of the upper part of the female reproductive system, mainly the uterus, fallopian tubes, and ovaries, and inside of the pelvis. [5] [2] Often, there may be no symptoms. [1]
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.